[New contributions on extinction tests of essential headache. III. The test with tiapride].
The Authors valued effects of the extinction-test with Thiapride (200 mg i.v.) in the primary headaches. They particularly noticed a significant reduction of PGF2-alpha and PRL, together with an increase of 5-HT and beta-ELI in CSF.
D000328:Adult; D001549:Benzamides / Q000627:therapeutic use*; D015237:Dinoprost; D004723:Endorphins / Q000134:cerebrospinal fluid; D006261:Headache / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011388:Prolactin / Q000134:cerebrospinal fluid; D011460:Prostaglandins F / Q000134:cerebrospinal fluid; D012701:Serotonin / Q000134:cerebrospinal fluid; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use*; D001615:beta-Endorphin
D001549:Benzamides; D004723:Endorphins; D011460:Prostaglandins F; D012701:Serotonin; D001615:beta-Endorphin; D011388:Prolactin; D015237:Dinoprost; D013976:Tiapamil Hydrochloride
Nuovi contributi su le prove di estinzione nelle cefalee essenziali: III) Il test con tiapride.